Glucagon-like peptide 1 receptor agonists (GLP-1 RAs), including structural analogues of human endogenous GLP-1 (albiglutide, dulaglutide, liraglutide, and semaglutide) and exendin-based agents (efpeglenatide, exenatide, and lixisenatide), are antidiabetic medications that share common glucose-lowering mechanisms, such as augmentation of glucose-induced insulin secretion, suppression of glucagon, and deceleration of gastric emptying (Heuvelman et al., 2020
Exception: Some prefilled pens allow home use under medical supervision
& Bunn, H
It is also the ideal solution for people who wish to reduce the size of their waists
Lancet 398 , 18111824 (2021)
Some users experience transient effects during the first 1-2 weeks including mild headaches, joint aches, and water retention